Literature DB >> 28664318

Sorafenib-Induced Acute Pancreatitis: Case Report and Review of the Literature.

Patrick Twohig1,2, Jaclyn Rivington3,4.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 28664318     DOI: 10.1007/s12029-017-9980-3

Source DB:  PubMed          Journal:  J Gastrointest Cancer


× No keyword cloud information.
  23 in total

1.  Sorafenib-induced pancreatitis.

Authors:  Surabhi Amar; Kevin J Wu; Winston W Tan
Journal:  Mayo Clin Proc       Date:  2007-04       Impact factor: 7.616

2.  Axitinib-induced acute pancreatitis: a case report.

Authors:  Julien Péron; Safia Khenifer; Valérie Potier; Thierry Vitry; Florian Pasquet; Robin Rassat; Michel Pavic
Journal:  Anticancer Drugs       Date:  2014-04       Impact factor: 2.248

Review 3.  Pancreatic ischaemia in experimental acute pancreatitis: mechanism, significance and therapy.

Authors:  E Klar; K Messmer; A L Warshaw; C Herfarth
Journal:  Br J Surg       Date:  1990-11       Impact factor: 6.939

4.  Tyrosine kinase inhibitor induced pancreatitis.

Authors:  Adrienne Sevin; Adrienne Chen; Brad Atkinson
Journal:  J Oncol Pharm Pract       Date:  2012-10-03       Impact factor: 1.809

5.  Sorafenib in the treatment of advanced hepatocellular carcinoma.

Authors:  Ali Ben Mousa
Journal:  Saudi J Gastroenterol       Date:  2008-01       Impact factor: 2.485

6.  Sorafenib in advanced hepatocellular carcinoma.

Authors:  Josep M Llovet; Sergio Ricci; Vincenzo Mazzaferro; Philip Hilgard; Edward Gane; Jean-Frédéric Blanc; Andre Cosme de Oliveira; Armando Santoro; Jean-Luc Raoul; Alejandro Forner; Myron Schwartz; Camillo Porta; Stefan Zeuzem; Luigi Bolondi; Tim F Greten; Peter R Galle; Jean-François Seitz; Ivan Borbath; Dieter Häussinger; Tom Giannaris; Minghua Shan; Marius Moscovici; Dimitris Voliotis; Jordi Bruix
Journal:  N Engl J Med       Date:  2008-07-24       Impact factor: 91.245

Review 7.  Significant elevations of serum lipase not caused by pancreatitis: a systematic review.

Authors:  Ahmer M Hameed; Vincent W T Lam; Henry C Pleass
Journal:  HPB (Oxford)       Date:  2014-06-03       Impact factor: 3.647

8.  Pazopanib-Induced Severe Acute Pancreatitis.

Authors:  Kazumichi Kawakubo; Hiroo Hata; Hiroshi Kawakami; Masaki Kuwatani; Shuhei Kawahata; Kimitoshi Kubo; Keisuke Imafuku; Shinya Kitamura; Naoya Sakamoto
Journal:  Case Rep Oncol       Date:  2015-08-19

9.  Phase I/II Trial of Sorafenib in Combination with Vinorelbine as First-Line Chemotherapy for Metastatic Breast Cancer.

Authors:  Cristiano Ferrario; Ivan Strepponi; Khashayar Esfahani; Helen Charamis; Adrian Langleben; Emanuela Scarpi; Oriana Nanni; Wilson H Miller; Lawrence C Panasci
Journal:  PLoS One       Date:  2016-12-19       Impact factor: 3.240

10.  BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis.

Authors:  Scott M Wilhelm; Christopher Carter; Liya Tang; Dean Wilkie; Angela McNabola; Hong Rong; Charles Chen; Xiaomei Zhang; Patrick Vincent; Mark McHugh; Yichen Cao; Jaleel Shujath; Susan Gawlak; Deepa Eveleigh; Bruce Rowley; Li Liu; Lila Adnane; Mark Lynch; Daniel Auclair; Ian Taylor; Rich Gedrich; Andrei Voznesensky; Bernd Riedl; Leonard E Post; Gideon Bollag; Pamela A Trail
Journal:  Cancer Res       Date:  2004-10-01       Impact factor: 13.312

View more
  3 in total

1.  Novel Albumin Nanoparticle Enhanced the Anti-Insulin-Resistant-Hepatoma Activity of Metformin.

Authors:  Zhong Lu; Li Qi; Ya-Ru Lin; Lei Sun; Lin Zhang; Gui-Chun Wang; Jia-Qiu Li; Jin-Ming Yu
Journal:  Int J Nanomedicine       Date:  2020-07-23

2.  Drug induced pancreatitis: A systematic review of case reports to determine potential drug associations.

Authors:  Dianna Wolfe; Salmaan Kanji; Fatemeh Yazdi; Pauline Barbeau; Danielle Rice; Andrew Beck; Claire Butler; Leila Esmaeilisaraji; Becky Skidmore; David Moher; Brian Hutton
Journal:  PLoS One       Date:  2020-04-17       Impact factor: 3.240

3.  Sorafenib-Induced Acute Pancreatitis in a Patient with Differentiated Thyroid Cancer.

Authors:  Laura Ximena Kattah Martinez; Lisseth Fernanda Marín Carrillo; Leonardo Rojas Melo
Journal:  Eur Thyroid J       Date:  2018-04-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.